[2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] 3-methyl-2-(4-methylphenyl)quinoline-4-carboxylate
C27H20ClF3N2O3 — CID 17261521
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] 3-methyl-2-(4-methylphenyl)quinoline-4-carboxylate
[2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] 3-methyl-2-(4-methylphenyl)quinoline-4-carboxylate (PubChem CID 17261521) has the molecular formula C27H20ClF3N2O3 and a molecular weight of 512.92 g/mol. Its IUPAC name is [2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] 3-methyl-2-(4-methylphenyl)quinoline-4-carboxylate.
Molecular Properties
| Compound Name | [2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] 3-methyl-2-(4-methylphenyl)quinoline-4-carboxylate |
|---|---|
| PubChem CID | 17261521 |
| Molecular Formula | C27H20ClF3N2O3 |
| Molecular Weight | 512.92 g/mol |
| Exact Mass | 512.11 |
| IUPAC Name | [2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] 3-methyl-2-(4-methylphenyl)quinoline-4-carboxylate |
| SMILES | Cc1ccc(-c2nc3ccccc3c(C(=O)OCC(=O)Nc3cc(C(F)(F)F)ccc3Cl)c2C)cc1 |
| InChI | InChI=1S/C27H20ClF3N2O3/c1-15-7-9-17(10-8-15)25-16(2)24(19-5-3-4-6-21(19)33-25)26(35)36-14-23(34)32-22-13-18(27(29,30)31)11-12-20(22)28/h3-13H,14H2,1-2H3,(H,32,34) |
| InChIKey | KOKCJKHHEKMILG-UHFFFAOYSA-N |
| XLogP | 6.99 |
| TPSA | 68.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 512.92 |
| LogP ≤ 5 | 6.99 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 17261521 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.